previous
develop
asnglyarg
ngr
peptidemodifi
multifunct
poli
ethyleneimin
poli
ethylen
glycol
peipeg
base
nanoparticl
tpic
consid
promis
carrier
codeliveri
dna
doxorubicin
dox
continu
effort
aim
present
studi
evalu
interact
tpic
human
umbil
vein
endotheli
cell
huvec
better
understand
cellular
entri
mechan
present
investig
experi
relev
coloc
endocytosi
inhibitor
factor
influenc
intern
perform
without
treatment
coloc
aminopeptidas
caveolin
howev
coloc
observ
cell
incub
antibodi
tpic
compar
antibodi
treatment
tpic
acceler
speed
enhanc
degre
coloc
tpic
enter
huvec
togeth
also
togeth
howev
intern
depend
enzym
activ
could
inhibit
identifi
involv
caveolaemedi
endocytosi
cvme
conclus
also
verifi
endocytosi
inhibitor
experi
recent
year
gene
therapi
drug
target
studi
reveal
import
identifi
intracellular
mechan
effici
deliveri
understand
potenti
uptak
mechan
involv
cellular
entri
test
nanoparticl
could
help
provid
feedback
ration
design
improv
vector
accordingli
scientist
awar
characterist
typic
traffick
pathway
mani
target
therapeut
endocytosi
pathway
classic
clathrinmedi
endocytosi
cme
recent
character
detail
pathway
may
offer
altern
uptak
traffick
pathway
gene
deliveri
vector
caveolaemedi
endocytosi
cvme
gener
consid
nonacid
nondigest
uptak
rout
indic
sens
drop
ph
travel
phneutral
caveosom
directli
golgi
andor
endoplasm
reticulum
er
nuclear
entri
take
place
therebi
avoid
lysosom
degrad
cvme
character
evolut
caveola
small
flaskshap
nonclathrin
coat
invagin
hydrophob
membran
subdomain
enrich
cholesterol
glycosphingolipid
caveolin
protein
caveolin
protein
famili
three
member
caveolin
caveolin
caveolin
cav
among
major
structur
protein
caveola
possess
abil
interact
numer
protein
caveola
vascular
endotheli
cell
first
identifi
paladern
caveola
exist
alon
cluster
mani
type
mammalian
cell
particularli
epitheli
cell
endotheli
cell
fibroblast
adipocyt
smooth
muscl
cell
caveola
transport
bioactiv
molecul
cell
particip
recept
transduct
multipl
signal
recent
year
cell
physiolog
function
caveola
drawn
increas
attent
especi
signal
transduct
cholesterol
transport
cell
intern
tumor
suppress
muscl
cell
synthesi
addit
increas
number
studi
shown
caveola
close
relat
mani
diseas
includ
cancer
arteriosclerosi
muscular
dystrophi
earli
alzheim
diabet
characterist
cvme
attract
tremend
attent
field
gene
deliveri
research
among
attach
specif
ligand
polymerbas
carrier
target
cvme
becom
promis
approach
gene
therapi
aminopeptidas
type
ii
transmembran
protein
present
wide
varieti
human
organ
tissu
cell
type
endotheli
epitheli
fibroblast
leukocyt
multipl
function
relat
tumorigenesi
immun
system
pain
function
facilit
modul
bioactiv
peptid
respons
pain
manag
vasopressin
releas
also
influenc
bodi
immun
function
major
biolog
event
cell
prolifer
secret
invas
angiogenesi
therebi
provid
treatment
option
variou
diseas
specif
recogn
bound
specif
sequenc
asnglyarg
ngr
peptid
exhibit
high
affin
specif
toward
moieti
although
ubiquit
enzym
studi
express
pattern
normal
neoplast
human
tissu
suggest
differ
form
express
myeloid
cell
epithelia
tumorassoci
blood
vessel
isoform
function
vascular
receptor
ngr
motif
report
select
overexpress
tumor
vasculatur
tumor
cell
fact
mani
therapi
base
ngr
ngrdrug
conjug
ngrcoat
liposom
http
wwwambriliacom
ngrcoat
pegbpla
polymer
micel
ngrmodifi
pegyl
lpd
liposomepolycationdna
nanoparticl
cngrcpegpeidna
vector
gene
therapi
clinic
late
preclin
develop
strategi
target
ngr
tumor
therapi
wide
accept
character
newli
develop
formul
import
develop
vasculartarget
therapi
base
system
addit
previou
studi
report
particip
receptormedi
phagocytosi
current
increas
amount
evid
indic
tempor
specif
local
signal
molecul
play
critic
role
rapid
effici
signal
transduct
event
recent
variou
compound
particl
coupl
synthet
ngr
peptid
target
attempt
increas
tumor
target
properti
previou
studi
ngr
peptid
use
modifi
poli
lactic
acid
poli
ethylen
glycol
nanoparticl
plapeg
np
target
gene
deliveri
shown
ngrmodifi
plapeg
np
ngrplapeg
np
could
specif
enhanc
vitro
gene
transfect
effici
importantli
found
uniqu
mechan
cvme
mainli
involv
intern
ngrplapeg
np
huvec
accordingli
hypothes
ngrmodifi
nanocarri
might
induc
particular
signal
transduct
event
via
receptor
transport
posit
cell
cvme
howev
detail
work
establish
exact
cellular
uptak
mechan
current
lack
therefor
necessari
gain
insight
cellular
entri
mechan
gene
transfect
recent
ngrmodifi
multifunct
poli
ethyleneimin
poli
ethylen
glycol
peipeg
base
nanoparticl
tpic
develop
group
drug
gene
combin
therapi
could
enhanc
gene
transfect
effici
antitumor
activ
vitro
continu
effort
focu
proceed
studi
studi
exact
mechan
involv
clarifi
whether
ngr
interact
mediat
subsequ
cvme
present
studi
huvec
select
test
cell
previous
formul
tpic
test
nanocarri
use
flow
cytometri
confoc
laser
scan
technolog
present
investig
coloc
effect
tpic
coloc
interact
tpic
tpic
kinet
result
endocytosi
effect
endocytosi
inhibitor
factor
influenc
intern
tpic
plasmid
pcmvegfp
carri
gene
enhanc
green
fluoresc
protein
egfp
cytomegaloviru
cmv
promot
propag
escherichia
coli
purifi
endo
free
plasmid
maxi
kit
qiagen
hilden
germani
puriti
concentr
pdna
measur
nanodrop
uvvi
spectrophotomet
thermo
usa
phycoerythrin
pe
conjug
antihuman
monoclon
antibodi
clone
purchas
bd
bioscienc
usa
dylight
antihuman
caveolin
monoclon
antibodi
purchas
novu
biolog
usa
purchas
invitrogen
life
technolog
usa
cholesterol
bovin
serum
albumin
bsa
purchas
sigmaaldrich
usa
reagent
special
commerci
grade
use
without
purif
deioniz
water
use
throughout
experi
reagent
biochem
molecular
biolog
grade
obtain
sigmaaldrich
china
doxorubicin
dox
purchas
dalian
meilun
biolog
technolog
co
ltd
dalian
china
human
umbil
vein
endotheli
cell
huvec
purchas
sciencel
research
laboratori
san
diego
usa
cultur
suppli
endotheli
cell
medium
ecm
endotheli
cell
growth
supplement
ecg
fetal
bovin
serum
fb
penicillinstreptomycin
solut
ps
cell
cultur
incub
co
huvec
cultur
ecm
ecg
fb
ps
solut
incub
co
cell
detach
trypsinedta
cell
densiti
adjust
pb
grow
logarithm
phase
cell
incub
peconjug
monoclon
antibodi
specif
detect
express
dylight
antihuman
monoclon
antibodi
dilut
detect
express
h
wash
cold
pb
three
time
cell
resuspend
pb
analyz
fac
bd
bioscienc
usa
equip
argon
laser
excit
sampl
event
collect
fluoresc
detect
signal
amplifi
logarithm
mode
fluoresc
determin
posit
event
standard
gate
techniqu
percentag
posit
event
calcul
event
within
gate
divid
total
number
event
exclud
cell
debri
examin
suit
local
huvec
huvec
seed
glass
bottom
dish
complet
medium
cultur
media
remov
cell
attach
glass
cell
label
peconjug
antibodi
dilut
h
cell
wash
twice
cold
pb
fix
paraformaldehyd
moll
pb
min
final
fix
cell
examin
zeiss
laser
confoc
scan
microscop
observ
local
treat
huvec
cultur
glass
bottom
dish
corn
incorpor
usa
peconjug
antibodi
dilut
h
rins
cell
incub
h
fix
paraformaldehyd
moll
pb
min
cell
permeabil
triton
min
treat
bovin
serum
albumin
min
label
incub
huvec
dylight
antihuman
monoclon
antibodi
dilut
overnight
wash
three
time
pb
stain
perform
stain
nucleu
control
extens
wash
glass
bottom
dish
examin
zeiss
laser
confoc
scan
microscop
examin
whether
tpic
could
chang
distribut
manner
similar
antibodi
examin
behavior
cell
treat
tpic
tpic
without
dox
prepar
use
avoid
mutual
interfer
red
fluoresc
dox
pe
first
huvec
incub
nondoxload
tpic
h
co
incub
test
nanocarri
aspir
cell
wash
three
time
cold
pb
fix
paraformaldehyd
moll
pb
min
cell
treat
peconjug
antibodi
dilut
h
permeabil
triton
min
treat
bovin
serum
albumin
min
label
describ
extens
wash
glass
bottom
dish
examin
zeiss
laser
confoc
scan
microscop
avoid
interfer
red
fluoresc
dox
pelabel
antibodi
facilit
observ
interact
tpic
green
fluoresc
label
nondoxload
nanocarri
need
studi
fam
ngr
use
prepar
green
fluorescentlabel
tpic
describ
previou
studi
examin
behavior
cell
treat
famtpic
h
test
nanoparticl
aspir
cell
wash
twice
cold
pb
ad
peconjug
antibodi
dilut
incub
h
cell
fix
stain
nuclear
examin
glass
bottom
dish
examin
zeiss
laser
confoc
scan
microscop
studi
interact
tpic
cell
treat
fresh
serum
free
media
contain
doxload
tpic
h
cell
fix
incub
dylight
antihuman
monoclon
antibodi
dilut
overnight
extens
wash
cell
stain
glass
bottom
dish
examin
confoc
scan
microscop
determin
whether
activ
affect
intern
tpic
huvec
pretreat
bestatin
inhibitor
h
room
temperatur
pb
cell
wash
three
time
pb
tpic
ad
well
incub
cell
anoth
h
co
incub
final
cell
harvest
wash
cellassoci
fluoresc
determin
fac
examin
influenc
cholesterol
deplet
treat
cell
mmoll
ecm
min
wash
three
time
pb
tpic
ad
well
incub
cell
anoth
h
co
incub
cell
harvest
wash
cellassoci
fluoresc
determin
fac
exclud
possibl
irrevers
damag
caus
treatment
incub
cell
complex
min
replenish
cholesterol
prepar
describ
previous
briefli
cholesterol
methanolchloroform
dri
suspend
moll
pb
buffer
solut
sonic
rotat
overnight
mixtur
filter
dilut
ecm
final
concentr
approxim
mmoll
cholesterol
studi
effect
cholesterol
deplet
interact
tpic
cell
pretreat
incub
tpic
previous
mention
fix
cell
incub
dylight
antihuman
monoclon
antibodi
dilut
overnight
extens
wash
cell
stain
glass
bottom
dish
examin
confoc
scan
microscop
evalu
endocytosi
kinet
tpic
huvec
transfect
dose
tpic
incub
huvec
min
h
min
h
incub
cultur
media
remov
cell
wash
three
time
cold
pb
cell
label
peconjug
antibodi
dilut
h
final
cell
wash
twice
cold
pb
tpic
uptak
surfac
access
huvec
incub
tpic
variou
time
period
determin
fac
studi
effect
endocyt
inhibitor
uptak
tpic
huvec
preincub
individu
follow
inhibitor
concentr
toxic
cell
chlorpromazin
min
genistein
min
mmoll
cytochalasin
min
follow
preincub
cell
treat
freshli
prepar
tpic
h
subsequ
cell
wash
three
time
pb
collect
accord
method
describ
analyz
fac
fluoresc
microscopi
studi
group
without
treatment
use
background
fac
analysi
wherea
group
presenc
tpic
without
inhibitor
treatment
use
control
studi
repeat
minimum
three
time
measur
least
triplic
result
report
mean
deviat
sd
statist
signific
analyz
use
student
ttest
differ
experiment
group
consid
signific
p
valu
less
p
quantit
result
fac
indic
posit
percentag
express
huvec
impli
nearli
huvec
posit
fig
local
huvec
examin
label
cell
situ
follow
analysi
confoc
microscop
concentr
site
cell
membran
began
project
filament
fig
suggest
role
adhes
motil
cell
data
line
report
role
express
tumor
cell
cell
adhes
use
antibodi
antibodi
label
huvec
respect
result
express
huvec
shown
fig
flow
cytometr
scatter
plot
use
quantit
analysi
fig
c
present
individu
control
pe
antihuman
label
dylight
antihuman
antibodi
label
cell
indic
avail
antibodi
fig
show
cell
posit
cell
express
could
label
antibodi
exhibit
red
fluoresc
pe
upper
left
corner
posit
could
label
antibodi
exhibit
green
fluoresc
fam
lower
right
corner
cell
express
show
upper
right
corner
quantit
data
demonstr
posit
percentag
respect
percentag
huvec
express
shown
fig
huvec
incub
antibodi
fix
without
warm
min
red
fluoresc
observ
evenli
cell
surfac
cell
label
observ
green
coloc
occur
cell
bound
antibodi
incub
min
label
huvec
surfac
show
uniform
punctat
distribut
coloc
observ
incub
time
min
label
show
spot
small
extent
coloc
observ
white
arrow
extend
incub
time
coloc
becam
frequent
min
white
arrow
incub
time
extend
h
gather
cluster
coloc
extens
white
arrow
result
demonstr
antibodi
bound
cell
surfac
evenli
incub
ice
bound
antibodi
becam
sequest
patch
temperatur
increas
addit
result
indic
bind
antibodi
incub
could
caus
cluster
coloc
result
excit
impli
target
could
initi
subsequ
interact
although
coloc
absenc
antibodi
accumul
crosslink
molecul
area
similar
previous
report
behavior
glycosylphosphatidylinositol
gpi
anchor
protein
glycosphingolipid
section
tri
examin
whether
tpic
could
chang
distribut
manner
similar
antibodi
examin
behavior
cell
treat
tpic
huvec
incub
tpic
use
procedur
antibodi
h
shown
fig
found
distribut
huvec
surfac
longer
uniform
punctuat
randomli
distribut
dot
h
differ
treat
antibodi
moreov
huvec
incub
tpic
fix
without
warm
h
coloc
small
cluster
alreadi
observ
fig
top
row
white
arrow
min
earlier
treat
antibodi
extens
incub
time
distribut
huvec
surfac
gather
cluster
extens
coloc
occur
h
howev
compar
coloc
result
antibodi
treatment
h
coloc
result
h
tpic
treatment
much
extens
result
indic
tpic
could
chang
distribut
differ
manner
antibodi
tpic
could
acceler
speed
enhanc
extent
coloc
compar
antibodi
addit
coloc
also
appear
cytoplasm
suggest
tpic
treatment
could
enter
cell
membran
coloc
cytoplasm
period
time
section
tri
examin
interact
tpic
previou
studi
alreadi
indic
ngrmediat
nanocarri
entri
huvec
energi
depend
activ
process
present
studi
uptak
significantli
inhibit
tpic
mainli
stay
cell
surfac
enter
cell
although
tpic
scatter
cell
membran
green
spot
coloc
red
yellow
fig
indic
tpic
could
bind
cell
surfac
green
fluoresc
observ
figur
immunofluoresc
microscopi
huvec
treat
pelabel
mous
antihuman
antibodi
firstli
incub
min
h
white
arrow
indic
coloc
insid
cell
indic
tpic
taken
cell
extens
condit
coloc
red
observ
green
tpic
yellow
orang
dot
accumul
perinuclear
area
indic
tpic
interact
enter
cell
fig
result
indic
tpic
first
bind
cell
surfac
enter
huvec
intern
tpic
suggest
might
particip
cellular
uptak
tpic
result
shown
fig
red
tpic
green
overlap
yellow
stain
demonstr
tpic
could
coloc
extent
coloc
increas
concentr
around
perinuclear
area
suggest
tpic
enter
huvec
togeth
particip
intern
tpic
coloc
behavior
tpic
similar
produc
combin
tpic
differ
tpic
could
caus
cluster
bestatin
potent
inhibitor
inhibit
activ
exert
antitumor
activ
concentr
bestatin
chosen
sinc
shown
effect
inhibit
enzym
activ
nontox
cell
result
inhibit
studi
enzym
activ
shown
fig
without
bestatin
treatment
tpic
could
effici
intern
huvec
posit
percentag
bestatin
treatment
tpic
also
effici
intern
huvec
significantli
suppress
suggest
intern
tpic
huvec
depend
enzym
activ
caveola
invagin
membran
structur
enrich
cholesterol
sphingomyelin
caveolin
protein
integr
sphingolipidand
cholesterolrich
microdomain
depend
cholesterol
examin
whether
behavior
tpic
chang
plasmalemm
cholesterol
deplet
use
deplet
cholesterol
cell
membran
therebi
select
destroy
format
caveola
accord
fac
analysi
fig
amount
intern
tpic
significantli
inhibit
cholesterol
deplet
replenish
cholesterol
affect
amount
tpic
intern
exogen
cholesterol
significantli
revers
effect
furthermor
addit
exogen
cholesterol
alon
chang
amount
intern
tpic
amount
tpic
intern
decreas
significantli
cholesteroldeplet
cell
recov
control
level
cholesteroldeplet
replenish
cell
demonstr
cholesterol
deplet
inhibit
intracellular
entri
tpic
treatment
coloc
tpic
also
evalu
determin
import
role
caveola
tpic
intern
shown
fig
coloc
tpic
decreas
significantli
pretreat
without
tpic
coloc
perinuclear
area
larg
extent
howev
treatment
cell
cholesterol
deplet
integr
caveola
destroy
therebi
distribut
becam
discontinu
cell
surfac
gather
cluster
consequ
extent
coloc
tpic
greatli
reduc
small
number
overlap
spot
appear
suggest
import
effect
caveola
intern
tpic
result
endocytosi
kinet
experi
shown
fig
shown
fig
tpic
uptak
enhanc
incub
time
increas
wherea
intern
tpic
inhibit
demonstr
endocyt
uptak
tpic
energydepend
mechan
addit
surfac
access
also
affect
temperatur
approxim
less
tpic
intern
result
decreas
surfac
access
rapid
intern
tpic
observ
uptak
tpic
increas
incub
time
interestingli
tpic
uptak
increas
amount
cell
surfac
appear
decreas
first
increas
follow
h
intern
tpic
increas
rapidli
reach
sharp
declin
surfac
reach
lowest
valu
find
impli
involv
endocytosi
process
tpic
h
tpic
endocytosi
process
continu
endocytosi
speed
reduc
lower
amount
cell
surfac
increas
extens
time
cell
could
return
cell
surfac
receptor
cycl
endocytosi
process
amount
surfac
dynam
chang
howev
time
point
recycl
continu
particip
uptak
process
tpic
intern
tpic
gradual
increas
nanoparticl
enter
cell
endocyt
pathway
select
inhibit
variou
pathway
initi
identifi
relev
intracellular
track
adopt
tpic
cell
intern
henc
huvec
treat
separ
inhibitor
differ
intern
rout
includ
cme
cvme
macropinocytosi
cell
incub
tpic
chlorpromazin
effect
inhibit
cme
treatment
chlorpromazin
min
result
inhibit
tpic
uptak
huvec
shown
fig
indic
cme
involv
although
involv
cme
previous
mention
type
transcellular
mechan
also
implic
previous
report
intracellular
traffic
experi
tpic
huvec
inhibit
cvme
test
use
genistein
tyrosin
kinas
inhibitor
report
inhibit
cvme
viru
treat
genistein
min
cell
uptak
tpic
significantli
decreas
fig
suggest
intern
tpic
mainli
cvme
cytochalasin
report
inhibit
actin
polymer
membran
ruffl
involv
macropinocytosi
cell
uptak
tpic
huvec
reduc
fig
cytochalasin
treatment
impli
macropinocytosi
major
cell
uptak
mechan
tpic
normal
condit
taken
togeth
endocyt
inhibit
studi
present
herein
indic
intern
tpic
huvec
combin
process
cme
cvme
rel
ratio
cme
cvme
nevertheless
uniqu
mechan
caveolaemedi
endocytosi
inde
mainli
involv
intern
consist
origin
hypothesi
previou
studi
tpic
develop
extens
character
averag
particl
size
zeta
potenti
tpic
nm
mv
respect
tpic
shown
promis
carrier
codeliveri
dna
dox
lead
effici
gene
transfect
antitumor
activ
vitro
extens
intracellular
studi
tpic
druggen
codeliveri
aim
present
studi
determin
ngrfunction
tpic
interact
target
cell
promot
intracellular
deliveri
process
ngr
peptid
show
highli
specif
recognit
also
report
aggreg
label
coloc
cell
base
find
previous
obtain
conclus
hypothes
ngr
might
abl
mediat
tpic
posit
cell
via
cvme
present
studi
verifi
coloc
without
treatment
fig
figur
tpic
uptak
surfac
access
huvec
incub
tpic
b
variou
time
point
min
howev
cell
incub
antibodi
coloc
observ
fig
min
h
excit
result
impli
target
could
initi
subsequ
interact
huvec
treat
tpic
greater
degre
coloc
found
shown
tpic
could
acceler
speed
enhanc
degre
coloc
greater
degre
antibodi
differ
could
attribut
differ
crosslink
degre
size
ligand
antibodi
compar
antibodi
ngrmodifi
nanocarri
suppos
polyval
ligand
therefor
treat
tpic
speed
extent
coloc
enhanc
compar
antibodi
notabl
although
pattern
less
conspicu
crosslink
molecul
tpic
treatment
show
streaki
distribut
along
longitudin
line
fig
fig
phenomenon
probabl
crosslink
tpic
would
induc
bind
actin
filament
either
directli
indirectli
caus
longitudin
align
similar
distribut
also
report
crosslink
eventu
intern
cvme
evalu
interact
tpic
found
tpic
could
bind
fig
enter
huvec
togeth
fig
howev
tpic
chang
distribut
huvec
caus
cluster
cluster
possibl
accumul
interact
ngr
tpic
surfac
aggreg
receptor
ubiquit
phenomenon
process
receptormedi
endocytosi
demonstr
group
presenc
tpic
without
inhibitor
treatment
control
fluoresc
intens
express
decreas
fluoresc
group
compar
control
suggest
potenti
mechan
intern
uptak
tpic
huvec
via
activ
target
endocytosi
moreov
tpic
complet
coloc
separ
enter
cell
might
need
separ
complex
recycl
cell
surfac
use
type
receptor
cycl
verifi
follow
endocytosi
kinet
experi
fig
subsequ
tpic
demonstr
coloc
enter
huvec
togeth
fig
howev
compar
interact
tpic
caus
cluster
suggest
coloc
tpic
result
receptorligand
interact
ngr
moreov
tpic
intern
independ
red
dot
suggest
might
mechan
independ
cme
verifi
cme
inde
involv
follow
endocytosi
inhibitor
experi
reveal
result
consist
hypothesi
previou
studi
report
differ
function
independ
exampl
antibodi
target
coronavirusbind
site
potenti
block
coronaviru
infect
without
interf
physiolog
function
demonstr
coronavirus
evolv
mechan
use
cell
entri
receptor
without
interf
physiolog
function
import
host
enzym
studi
result
verifi
intern
tpic
huvec
depend
enzym
activ
impli
tpic
might
also
use
cell
entri
receptor
without
interf
physiolog
function
way
coronavirus
use
deplet
cholesterol
cell
membran
therebi
damag
caveola
lead
block
intern
tpic
addit
coloc
tpic
also
inhibit
treatment
obvious
cholesterol
deplet
destroy
integr
caveola
affect
interact
tpic
inhibit
tpic
entri
cell
studi
support
import
role
caveola
tpic
entri
huvec
subsequ
inhibit
studi
also
suggest
intern
tpic
huvec
process
combin
cme
cvme
exist
cme
infer
previous
report
result
nevertheless
domin
intracellular
mechan
tpic
entri
huvec
cvme
result
consist
origin
hypothesi
base
previous
construct
tpic
systemat
studi
interact
carrier
target
cell
intracellular
deliveri
process
determin
whether
ngr
use
cvme
transport
tpic
posit
cell
result
indic
tpic
influenc
distribut
huvec
interact
ngr
caus
cluster
lead
coloc
intern
via
cvme
addit
intern
depend
enzym
activ
inhibit
cholesterol
deplet
paper
elucid
intracellular
mechan
multifunct
selfassembl
nanocarri
first
propos
ngr
mediat
nanocarri
enter
cell
cvme
elucid
mechan
crucial
understand
structurebioact
relationship
geneload
nanoparticl
import
make
contribut
direct
design
novel
drug
deliveri
system
